Study uncovers the role of mGluR1 in pruning early neural connections

FHS
July 1, 2024
1:53 pm

Not everything in the brain is meant to last. As our brains assemble, trillions of neural connections have to be built or torn down at the right time and place.

Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on

March 20, 2024

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Eli Lilly is set to build a new $2.5 billion facility in Germany to increase manufacturing capacity for its blockbuster diabetes and obesity drugs, and

November 18, 2023

Eli Lilly and Ro’s unlikely relationship

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.